secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001628280-23-028192
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies Avalo Therapeutics of bid price and MVLS non-compliance
-----------------------------------------------------------------------

- Bid price below $1.00 for 30 consecutive days; MVLS below $35M.
- Company has 180 days until Feb 5, 2024 to regain compliance.
- If not cured, may be eligible for additional 180-day period with reverse split plan.
- No immediate impact on listing; stock continues trading under AVTX.
- Company evaluating options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023028192/0001628280-23-028192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023028192/avtx-20230808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-028192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer